期刊文献+

PcDNA3.1-Tum-5基因真核表达载体的构建

The Construction of PcDNA3.1-Tum-5 Eukaryotic Expression Vectors
下载PDF
导出
摘要 目的构建携带Tum-5基因真核表达载体PcDNA3.1-Tum-5。方法利用巢式PCR扩增人胚肾细胞株HEK293 cDNA获得Tum-5基因,并利用DNA回收试剂盒进行回收;同时扩增、提取pcDNA3.1质粒,并将其与Tum-5基因分别进行EcoRV和XhoI双酶切,回收相应条带,通过T4DNA连接酶进行连接,转化DH5α感受态细胞,获得阳性克隆。获得质粒DNA后行KpnI和XhoI双酶切,克隆并测序酶切产物。结果巢式PCR扩增出的产物与目的基因大小相同;重组质粒经双酶切电泳分析,与预期结果一致;对连接点两端进行测序,结果显示接头两端序列连接正确,插入序列与载体读码框架相匹配。结论本方法可以成功构建人Tum-5基因表达载体,为进一步研究Tum-5基因功能提供了理论依据。 Objective To construct PcDNA3.1-Tum-5 eukaryotic expression vector carrying Tum-5 genes.Methods Tum-5 genes were constructed from human embryonic kidney cell line HEK293 cDNA by using nested PCR and DNA extraction kit.PcDNA3.1 plasmid was amplified and extracted simultaneously.The Tum-5 genes and PcDNA3.1 plasmid received EcoRV and XhoI double digestions respectively,recovery corresponding bands were connected by T4DNA ligase,transformed DH5α competent cells,and obtained positive clones.Plasmid DNA received KpnI and XhoI double digestions,digestion products were cloned and sequenced.Results Production amplified by nested PCR had the same size with the target genes;the analytic results of recombinant plasmid by double digestion electrophoresis were consistent with the expected results.Both ends of the connection points were sequenced,the results showed the connection of sequences were correct at both ends,the inserted sequences matched with vector reading frame.Conclusion Tum-5 gene expression vector is constructed successfully in this way.This lays the foundation for the further study of Tum-5 gene function.
出处 《肿瘤基础与临床》 2010年第6期461-463,共3页 journal of basic and clinical oncology
基金 福建省高等学校优秀人才支持计划项目(编号:NCETFJ-066)
关键词 肿瘤抑素 质粒 Tum-5基因 巢式PCR tumstatin plasmid Tum-5 gene nested PCR
  • 相关文献

参考文献9

  • 1Folkman J. Tumor angiogenesis : therapeutic implications [J]. N Engl J Med,1971, 285(21):1182-1186.
  • 2Maeshima Y, Colorado PC, Torre A,et al. Distinct antitumor proper- ties of a type 1V collagen domain derived from basement membrane [J]. J Biol Chem,2000,275(28) :21340 -21345.
  • 3Hamano Y, KaUuri R. Tumstatin, the NC1 domain of alpha3 chain of type 1V collagen, is an endogenous inhibitor of pathological angiogen- esis and suppresses tumor growth [J]. Biochem Biophys Res Commun, 2005,333 (2) :292-298.
  • 4Maeshima Y, Yerramalla UL, Dhanabal M,et al. Extracellular ma-trix-derived peptide binds to alpha (v)beta (3) integfin and inhibits angiogenesis[J]. J Biol Chem, 2001,276 (34) :31959-31968.
  • 5Hamano Y, Zeisberg M, Sugimoto H, et al. Physiological levels of tumstatin, a fragment of collagen 1V alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 in/e-grin [J]. Cancer Cell, 2003 ,3 (6) :589-601.
  • 6Maeshima Y, Colorado PC, Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct antl-tumor properties[J]. J Biol Chem, 2000,275 (31) :23745-23750.
  • 7Shahan TA, Ziale Z, Pasco S,et al. Identification of CD47/integrin- associated protein and alpha(v) beta3 as two receptors for the alpha3 (IV) chain of type 1V collagen on tumor cells [J]. Cancer Res, 1999,59(18) :4584-4590.
  • 8Pedchenko V, Zent R, Hudson BG. Alpha(v) be:a3 and alpha(v) beta5 integrins bind both the proximal RGD site and non-RGD motifs within nonconagenous (NCI) domain of the alpha3 chain of type 1V collagen: implication for the mechanism of endothelia cell adhesion [J]. J Biol Chem, 2004 ,279 (4) :2772-2780.
  • 9Maeshima Y, Manfredi M, Reimer C, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin [J]. J Biol Chem,2001,276(18):15240-15248.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部